Cardinal Health (NYSE: CAH), a US-based pharmaceuticals distributor, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities, announced its quarterly dividend on Thursday.
The company has declared a quarterly dividend of USD0.5056 per share out of the company's capital surplus.
The dividend will be paid to shareholders of record at 1 October 2024 on 15 October 2024.
Amgen announces Q3 2024 dividend
Perrigo announces quarterly dividend
Valneva receives CEPI funding to boost access to world's first chikungunya vaccine
Emmaus Life Sciences reports 2023 financial results
Quest Diagnostics to acquire LifeLabs from OMERS for USD1.35bn
Eli Lilly announces Q3 2024 dividend
Valneva's chikungunya vaccine IXCHIQ approved by Health Canada